Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Cipla
Accenture
Medtronic
Citi
Farmers Insurance
Argus Health
Queensland Health

Generated: April 24, 2018

DrugPatentWatch Database Preview

NATURAL ESTROGENIC SUBSTANCE-ESTRONE Drug Profile

« Back to Dashboard

When do Natural Estrogenic Substance-estrone patents expire, and when can generic versions of Natural Estrogenic Substance-estrone launch?

Natural Estrogenic Substance-estrone is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in NATURAL ESTROGENIC SUBSTANCE-ESTRONE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
Drug patent expirations by year for NATURAL ESTROGENIC SUBSTANCE-ESTRONE
Medical Subject Heading (MeSH) Categories for NATURAL ESTROGENIC SUBSTANCE-ESTRONE
Synonyms for NATURAL ESTROGENIC SUBSTANCE-ESTRONE
(+)-Estrone
(+/-)-Estrone
(+/-)-Oestrone
(13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one
(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one
(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-2,4,6-trien-14-one
(1S,10R,11S,15S)-5-HYDROXY-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2,4,6-TRIEN-14-ONE
(1S,10R,11S,15S)-5-HYDROXY-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2(7),3,5-TRIEN-14-ONE
(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadeca-2,4,6-trien-14-one
(8R,9S,13S,14S)-3-hydroxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17H-cyclopenta[a]phenanthren-17-one
(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
[2,4,6,7-3H]-E1
[2,4,6,7-3H]-Estrone
003E620
1,3,5(10)-Estratrien-3-ol-17-one
1,3,5(10)-Oestratrien-3-ol-17-one
19973-76-3
2DI9HA706A
3-08-00-01171 (Beilstein Handbook Reference)
3-Hydroxy-1,3,5(10)-estratrien-17-one
3-Hydroxy-17-keto-estra-1,3,5-triene
3-Hydroxy-17-keto-oestra-1,3,5-triene
3-hydroxy-estra-1,3,5(10)-trien-17-one
3-hydroxy-estra-1,3,5(10)-triene-17-one
3-Hydroxy-oestra-1,3,5(10)-trien-17-one
3-Hydroxyestra-1,3,5(10)-trien-17-one
3-Hydroxyestra-1,3,5(10)-triene-17-one
3-Hydroxyestra-1(10),2,4-trien-17-one
3-hydroxyl-1,3,5(10)-estratien-17-one
3-Hydroxyoestra-1,3,5(10)-trien-17-one
37242-41-4
53-16-7
86C77018-146D-4603-ACEA-CA0D8C4F1E2C
AB00382990
AB00382990_18
AB00382990-16
AB00382990-17
AB2000203
AC-1395
AC1L1LBE
ACN-032012
ACon0_000083
ACon1_000122
ACT02603
AJ-63983
AK120938
AKOS005622512
AKOS007930641
AN-195
Aquacrine
Aquest
BBL033470
BC676705
BDBM17289
BIDD:ER0145
Bio-0668
BL-090
bmse000549
BPBio1_000868
BRD-K81839095-001-04-6
BRN 1915077
BSPBio_000788
BT000383
C00468
CAS-53-16-7
CCG-204604
CCRIS 285
CHEBI:17263
CHEMBL1405
CMC_13458
Crinovaryl
Cristallovar
Crystogen
CS-2202
CTK7J9741
D00067
D00ZFP
D1,3,5(10)-Estratrien-3-ol-17-one
DB00655
delta-1,3,5-estratrien-3-beta-ol-17-one
delta-1,3,5-Estratrien-3beta-ol-17-one
delta-1,3,5-oestratrien-3-beta-ol-17-one
delta-1,3,5-Oestratrien-3beta-ol-17-one
Destrone
Disynformon
DNXHEGUUPJUMQT-CBZIJGRNSA-N
DSSTox_CID_2367
DSSTox_GSID_22367
DSSTox_RID_76560
DTXSID4022367
E 9750
E(sub 1)
E0026
EBD2157889
EINECS 200-164-5
Endofolliculina
Esterone
Estra-1,3,5(10)-trien-17-one, 3-hydroxy-
Estra-1,3,5(10)-trien-17-one, 3-hydroxy-, (+/-)-
estra-1(10),2,4-trien-17-one, 3-hydroxy-
Estrin
Estrogenic Substance
estrol
Estron
Estrona
Estrona [INN-Spanish]
Estrona [Spanish]
estrone
Estrone (E1)
Estrone (JAN/USP/INN)
Estrone (TN)
Estrone [USAN:INN]
Estrone [USP:INN:BAN]
Estrone 1.0 mg/ml in Methanol
Estrone 100 microg/mL in Acetonitrile
Estrone DL-form [MI]
Estrone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Estrone-A
Estrone, (+-)-Isomer
Estrone, (+/-)-
Estrone, (8 alpha)-Isomer
Estrone, (9 beta)-Isomer
Estrone, >=99%
Estrone, European Pharmacopoeia (EP) Reference Standard
Estrone, meets USP testing specifications
Estrone, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Estrone, United States Pharmacopeia (USP) Reference Standard
Estrone, VETRANAL(TM), analytical standard
Estronum
Estronum [INN-Latin]
estrovarin
Estrugenone
Estrusol
EU-0100513
Fem-O-Gen
Femestrone inj.
Femestrone injection
Femidyn
Fermidyn
Folikrin
Folipex
Folisan
Follestrine
Follestrol
follicular hormone
folliculin
Folliculine
Folliculine benzoate
Follicunodis
Glandubolin
GTPL2818
Hauck Brand of Estrone
Hiestrone
HMS1570H10
HMS2090E22
HMS2097H10
HMS2232O15
HMS3261H07
Hormestrin
Hormofollin
Hormovarine
HSDB 3324
HY-B0234
hydroxyestrones
Hyrex Brand of Estrone
Kestrone
Ketodestrin
Ketohydroxy-Estratriene
Ketohydroxyestrin
Ketohydroxyoestrin
Ketophydroxyestrin
Kolpon
LMST02010004
Lopac0_000513
LP00513
LS-64884
MEGxm0_000444
Menagen
Menformon
Menformon A
Mestronaq
MFCD00003620
MLS000028475
MLS001077340
MLS002695951
MLS006011890
MolPort-001-742-529
NCGC00015423-03
NCGC00023643-03
NCGC00023643-04
NCGC00023643-05
NCGC00023643-06
NCGC00023643-07
NCGC00023643-08
NCGC00023643-09
NCGC00023643-10
NCGC00023643-11
NCGC00023643-12
NCGC00023643-13
NCGC00023643-15
NCGC00179433-01
NCGC00179433-02
NCGC00179433-03
NCGC00257402-01
NCGC00258926-01
NCGC00261198-01
NSC 9699
Oestrin
Oestroform
OESTRONE
Oestrone [Steroidal oestrogens]
Oestrone, Estrone
Oestronum
Oestroperos
Opera_ID_330
Ovex (tablets)
Ovifollin
Penncap M
Perlatan
PL004749
PL058713
Prestwick0_000914
Prestwick1_000914
Prestwick2_000914
Prestwick3_000914
Q-201073
s1665
SCHEMBL21702
SGCUT00128
SMP1_000123
SMR000058338
Solliculin
SPBio_002977
Spectrum5_002047
SR-01000000085
SR-01000000085-3
ST24046696
STK801833
Theelin
Thelestrin
Thelykinin
Thynestron
to_000049
Tokokin
Tox21_113567
Tox21_113567_1
Tox21_201375
Tox21_303651
Tox21_500513
Unden
Unden (pharmaceutical)
Unden (pharmaceutical) (VAN)
Unigen
UNII-2DI9HA706A
UNII-X9XKA379T9 component DNXHEGUUPJUMQT-CBZIJGRNSA-N
Vortech Brand of Estrone
Wehgen
Wynestron
WynestronPencap M
X-1332
Z1695906713
ZINC13509425

US Patents and Regulatory Information for NATURAL ESTROGENIC SUBSTANCE-ESTRONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs NATURAL ESTROGENIC SUBSTANCE-ESTRONE estrone INJECTABLE;INJECTION 085237-001 Nov 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
McKesson
Chinese Patent Office
Express Scripts
Argus Health
Accenture
Baxter
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.